Transcriptional Signals of T-cell and Corticosteroid-sensitive Genes Are Associated With Future Acute Cellular Rejection in Cardiac Allografts

Journal of Heart and Lung Transplantation

Volumn 26, Issue 12, 2007, Pages 1255-1263

  Mehra, Mandeep R ^a   Kobashigawa, Jon A ^b   Deng, Mario C ^c   Fang, Kenneth C ^d   Klingler, Tod M ^d   Lal, Preeti G ^d   Rosenberg, Steven ^d   Uber, Patricia A ^a   Starling, Randall C ^e   Murali, Srinivas ^f   Pauly, Daniel F ^g   Dedrick, Russell ^d   Walker, Michael G ^d   Zeevi, Adriana ^h   Eisen, Howard J ⁱ  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d XDx Inc   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f ALLEGHENY GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CELL SURFACE RECEPTOR; CORTICOSTEROID; CYCLOSPORIN; GENE PRODUCT; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROGRAMMED CELL DEATH 1 PROTEIN; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; EFFECTOR CELL; FEMALE; FLT3 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IL1R2 GENE; IMMUNOCOMPETENT CELL; MALE; PDCD1 GENE; PRIORITY JOURNAL; RNA ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD11B; APOPTOSIS REGULATORY PROTEINS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, INTERLEUKIN-1 TYPE II; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 37249046582     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.009     Document Type: Article

References (26)

1. Felkel T.O., Smith A.L., Reichenspurner H.C., et al. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant 21 (2002) 530-539
2. Kirklin J.K., Naftel D.C., Bourge R.C., et al. Rejection after cardiac transplantation. A time-related risk factor analysis. Circulation 86 suppl (1992) 236-241 II
3. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant 9 (1990) 587-593
4. Caves P.K., Stinson E.B., Billingham M.E., and Shumway N.E. Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet 1 (1974) 821-826
5. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
6. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
7. Starling R.C., Pham M., Valantine H., et al. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant 25 (2006) 1389-1395
8. Yamani M.H., Taylor D.O., Haire C., Smedira N., and Starling R.C. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression. Clin Transplant 21 (2007) 523-525
9. Yamani M.H., Taylor D.O., Rodriguez E.R., et al. Transplant vasculopathy is associated with increased AlloMap gene expression score. J Heart Lung Transplant 26 (2007) 403-406
10. Marboe C.C., Billingham M., Eisen H., et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant 24 suppl (2005) S219-S226
11. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57 (1995) 289-300
12. Galon J., Franchimont D., Hiroi N., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 (2002) 61-71
13. Ayroldi E., Zollo O., Macchiarulo A., et al. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol 22 (2002) 7929-7941
14. Hubler T.R., and Scammell J.G. Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9 (2004) 243-252
15. Ito K., Yamamura S., Essilfie-Quaye S., et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203 (2006) 7-13
16. Koga N., Suzuki J., Kosuge H., et al. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler Thromb Vasc Biol 24 (2004) 2057-2062
17. Petrovas C., Casazza J.P., Brenchley J.M., et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203 (2006) 2281-2292
18. Trautmann L., Janbazian L., Chomont N., et al. Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction. Nat Med 12 (2006) 1198-1202
19. Ozkaynak E., Wang L., Goodearl A., et al. Programmed death-1 targeting can promote allograft survival. J Immunol 169 (2002) 6546-6553
20. Agata Y., Kawasaki A., Nishimura H., et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8 (1996) 765-772
21. Costello R., Cerdan C., Lipcey C., et al. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules. Cell Growth Differ 4 (1993) 947-954
22. Garcia-Sanz J.A., MacDonald H.R., Jenne D.E., Tschopp J., and Nabholz M. Cell specificity of granzyme gene expression. J Immunol 145 (1990) 3111-3118
23. Lennon G.P., Sillibourne J.E., Furrie E., Doherty M.J., and Kay R.A. Antigen triggering selectively increases TCRBV gene transcription. J Immunol 165 (2000) 2020-2027
24. Martin M., Huguet J., Centelles J.J., and Franco R. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155 (1995) 4630-4643
25. Chklovskaia E., Nissen C., Landmann L., et al. Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A. Blood 97 (2001) 1027-1034
26. Barber D.L., Wherry E.J., Masopust D., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682-687